Ratings by Canaccord (William Maughan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/6/2025 | Y-mAbs Therapeutics | YMAB | Downgrade | Hold (Buy) |
4.19 (8.61) |
105.49% | Details | |
| 3/21/2024 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2024 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | Xencor, Inc. | XNCR | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2023 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2023 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2023 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2023 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2023 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2023 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2023 | Xencor, Inc. | XNCR | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2022 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2022 | Neoleukin Therapeutics | NLTX | Downgrade | Hold (Buy) |
0.54 (3.49) |
546.3% | Details | |
| 11/9/2022 | Xencor, Inc. | XNCR | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2022 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2022 | Y-mAbs Therapeutics | YMAB | New Coverage | (N/A) |
16.17 (8.61) |
-46.75% | Details | |
| 7/6/2022 | Xencor, Inc. | XNCR | New Coverage | Buy (N/A) |
30.45 (11.32) |
-62.82% | Details | |
| 7/6/2022 | Olema Pharmaceuticals | OLMA | New Coverage | Buy (N/A) |
4.48 (21.55) |
381.03% | Details | |
| 7/6/2022 | Neoleukin Therapeutics | NLTX | New Coverage | Buy (N/A) |
1.01 (3.49) |
245.54% | Details | |
| 7/6/2022 | Harpoon Therapeutics | HARP | New Coverage | Buy (N/A) |
2.02 (23.01) |
1039.11% | Details | |
| 7/6/2022 | BioNTech | BNTX | New Coverage | Buy (N/A) |
161.03 (101.50) |
-36.97% | Details | |
| 7/6/2022 | Bicycle Therapeutics | BCYC | New Coverage | Buy (N/A) |
18.47 (5.19) |
-71.9% | Details |
